EVC2 and breast cancer: In addition, underlying the FARG signature, it was first observed that PRRC2A, ABCA8, ZDBF2, LIPE, ATP7B, DNAH11, MCTP1, LRRC37A3, and EVC2 gene alterations were correlated with prolonged OS of BC patients, but altered SUPT20H might be associated with shortened OS.